瑞科生物-B(02179)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02179 瑞科生物-B

已收盘 02-13 15:20:25

4.370

-0.570

-11.54%

最高4.700	最低4.340	成交量1.35万
今开4.500	昨收4.940	日振幅7.29%
总市值27.36亿	流通市值13.81亿	总股本6.26亿
成交额6.05万	换手率0.00%	流通股本3.16亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02179","market":"HK","secType":"STK","nameCN":"瑞科生物-B","latestPrice":4.37,"timestamp":1770967225444,"preClose":4.94,"halted":0,"volume":13500,"delay":0,"changeRate":-0.11538461538461543,"floatShares":316000000,"shares":626000000,"eps":-1.164922,"marketStatus":"已收盘","change":-0.57,"latestTime":"02-13 15:20:25","open":4.5,"high":4.7,"low":4.34,"amount":60455,"amplitude":0.072874,"askPrice":4.48,"askSize":5000,"bidPrice":4.37,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-1.145,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771205400000},"marketStatusCode":5,"adr":0,"listingDate":1648656000000,"exchange":"SEHK","adjPreClose":4.94,"openAndCloseTimeList":[[1770946200000,1770955200000],[1770958800000,1770969600000]],"volumeRatio":0.681818,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02179","defaultTab":"news","newsList":[{"id":"2609757567","title":"瑞科生物-B(02179):联交所就公司H股全流通计划授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2609757567","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609757567?lang=zh_cn&edition=full","pubTime":"2026-02-06 19:33","pubTimestamp":1770377606,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞科生物-B(02179)发布公告，公司已收到联交所于2026年2月5日授出的就1.42亿股H股上市及买卖的批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑞科生物-B(02179):联交所就公司H股全流通计划授出上市批准","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"1154937651","title":"瑞科生物（02179）更新1月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1154937651","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154937651?lang=zh_cn&edition=full","pubTime":"2026-02-02 17:03","pubTimestamp":1770022995,"startTime":"0","endTime":"0","summary":"江蘇瑞科生物技術股份有限公司（“瑞科生物”，02179）于2026年2月2日发布2026年1月股份变动月报表。公告显示，截至1月底，公司注册股本总额为人民币626,075,702元，其中内资股297,937,013股、非上市外资股12,000,000股、已发行H股316,138,689股，各类股份数量与上月保持一致。\n根据月报，本月未发生新增股份发行、购回或注销，也未出现库存股变动。公司确认已遵守香港联交所《上市规则》和相关法律法规。本次公告由董事刘勇签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"gpt_icon":0},{"id":"2608288026","title":"瑞科生物-B：中国证监会就公司H股全流通计划出具备案通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2608288026","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608288026?lang=zh_cn&edition=full","pubTime":"2026-02-02 08:58","pubTimestamp":1769993880,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　瑞科生物-B（02179）发布公告，公司已于近期收到中国证监会就本次H股全流通向公司出具的日期为2026年1月13日的备案通知书。根据备案通知书，公司已就28名股东所持有的合计1.42亿股未上市股份转换为H股完成向中国证监会作出备案。备案通知书自2026年1月13日起12个月内有效。公司将向联交所申请批准相关H股上市及买卖。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-02-02/doc-inhkkquq8154370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2607041707","title":"瑞科生物-B(02179)：中国证监会就公司H股全流通计划出具备案通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2607041707","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607041707?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:42","pubTimestamp":1769784157,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞科生物-B(02179)发布公告，公司已于近期收到中国证监会就本次H股全流通向公司出具的日期为2026年1月13日的备案通知书。根据备案通知书，公司已就28名股东所持有的合计1.42亿股未上市股份转换为H股完成向中国证监会作出备案。备案通知书自2026年1月13日起12个月内有效。公司将向联交所申请批准相关H股上市及买卖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400130.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑞科生物-B(02179)：中国证监会就公司H股全流通计划出具备案通知书","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2606675718","title":"瑞科生物境内未上市股份“全流通”获中国证监会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2606675718","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606675718?lang=zh_cn&edition=full","pubTime":"2026-01-28 09:26","pubTimestamp":1769563599,"startTime":"0","endTime":"0","summary":"南方财经1月28日电，中国证监会国际合作司发布关于江苏瑞科生物技术股份有限公司境内未上市股份“全流通”备案通知书，公司28名股东拟将所持合计141,953,489股境内未上市股份转为境外上市股份，并在香港联合交易所上市流通。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601283633137679.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2603950262","title":"A股、港股医药股今日大涨，这些利好因素在刺激","url":"https://stock-news.laohu8.com/highlight/detail?id=2603950262","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603950262?lang=zh_cn&edition=full","pubTime":"2026-01-13 11:37","pubTimestamp":1768275475,"startTime":"0","endTime":"0","summary":"1月13日上午，A股以及港股的医药股集体出现走强趋势。当前，已有重磅对外授权交易揭晓。这笔交易刺激了A股、港股市场中的一些双抗概念股股价大涨，1月13日上午，宜明昂科港股股价盘中涨幅一度超过10.10%；三生国健A股股价涨幅也超过4%。同样，A股以及港股的医药外包股齐齐出现股价大涨局面，如药明康德A股跟港股上午盘中股价涨幅超过6%；药明生物股价涨幅也超过5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113113932a4bcec89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113113932a4bcec89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417516738.SGD","LU0823426308.USD","LU1969619763.USD","02269","LU0516422952.EUR","LU0051755006.USD","BK1610","LU0052750758.USD","09939","LU0588546209.SGD","LU0320764599.SGD","LU0359201612.USD","LU0819121731.USD","02179","LU0307460666.USD","BK1574","09995","BK1515","BK1576","LU0516422366.SGD","LU0516423174.USD","IE00B0JY6N72.USD","LU0348825331.USD","LU0856984785.SGD","LU0456827905.SGD","LU1720050803.USD","LU1242518857.USD","LU2328871848.SGD","LU1688375341.USD","LU0359202008.SGD","LU1794554557.SGD","BK1161","LU0181495838.USD","LU3063872942.SGD","LU0417516902.SGD","LU0979878070.USD","LU2039709279.SGD","LU0708995583.HKD","LU1880383366.USD","LU0516422440.USD","01541","LU0823426480.USD","LU0039217434.USD","LU0043850808.USD","LU0327786744.USD","LU1242518931.SGD","SG9999002562.SGD","02126","02616","LU0516423091.SGD"],"gpt_icon":0},{"id":"2595736950","title":"瑞科生物-B(02179)：新佐剂重组带状疱疹疫苗REC610的新药上市申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2595736950","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595736950?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:49","pubTimestamp":1767019784,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞科生物-B 发布公告，公司新佐剂重组带状疱疹疫苗REC610 的新药上市申请已于近日获国家药品监督管理局药品审评中心正式受理，受理号：CXSS2500145。据统计，中国每年约有600万人罹患带状疱疹，且近年来其发病有逐步年轻化的趋势。目前，全球范围内新佐剂重组带状疱疹疫苗仅有葛兰素史克Shingrix上市销售。该项临床研究采用随机、双盲、安慰剂对照设计，旨在评估REC610疫苗对40岁及以上健康受试者的保护效力、安全性及免疫原性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386827.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02179","159646","BK1161"],"gpt_icon":0},{"id":"2594963452","title":"“隐形药王”扬子江 8 亿元入局！徐浩宇打破“不搞兼并”家训操盘瑞科生物，押注创新疫苗生死局","url":"https://stock-news.laohu8.com/highlight/detail?id=2594963452","media":"华夏时报网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594963452?lang=zh_cn&edition=full","pubTime":"2025-12-26 20:06","pubTimestamp":1766750764,"startTime":"0","endTime":"0","summary":"一纸人事公告，击穿扬子江药业“不搞兼并”的家训，创新疫苗赛道的生死棋局，骤然落子。近日，江苏瑞科生物技术股份有限公司（02179.HK）发布重磅人事公告，创始人刘勇博士正式辞去董事长及提名委员会主席职务。公告明确，刘勇辞任的核心原因是“进一步提升公司治理水平”及“计划倾注更多时间于其他工作”，辞任后仍将继续担任公司执行董事及总经理，全面主持生产经营管理工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512263603179188.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512263603179188.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159646","02179","BK1161"],"gpt_icon":0},{"id":"2593492550","title":"瑞科生物-B(02179)：选举徐浩宇担任董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2593492550","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593492550?lang=zh_cn&edition=full","pubTime":"2025-12-23 19:47","pubTimestamp":1766490448,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞科生物-B 发布公告，公司董事会于2025年12月22 日收到刘勇博士的辞职报告。为了进一步提升公司治理水平及计划倾注更多时间于其他工作，刘勇博士辞去公司董事长及董事会提名委员会主席职务，自董事会选举产生新任董事长之日起生效。董事会欣然宣布，董事会于2025年12月23日召开的董事会会议上选举徐浩宇先生担任公司第二届董事会董事长，任期自董事会审议通过之日起至第二届董事会任期届满之日止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385094.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2592198631","title":"瑞科生物-B(02179)：魏其芳、王静获委任为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2592198631","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592198631?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:32","pubTimestamp":1766154768,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞科生物-B(02179)发布公告，建议取消监事会的议案已经临时股东大会审议通过。据此，自2025年12月19日起，公司将不再设置监事会并废止《江苏瑞科生物技术股份有限公司监事会议事规则》，由董事会下设的审计委员会行使公司法及监管规定赋予的监督职能。公司现任监事会成员不再担任公司监事。于临时股东大会上，徐浩宇先生获委任为非执行董事;魏其芳先生获委任为执行董事;及王静女士获委任为执行董事。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑞科生物-B(02179)：魏其芳、王静获委任为执行董事","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2592944918","title":"瑞科生物-B(02179)完成定向发行内资股","url":"https://stock-news.laohu8.com/highlight/detail?id=2592944918","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592944918?lang=zh_cn&edition=full","pubTime":"2025-12-17 21:29","pubTimestamp":1765978156,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞科生物-B(02179)发布公告，本公司于2025年12月17日收到中国证券登记结算有限责任公司就本次发行出具的日期为2025年12月15日的股份登记证明，据此，1.43亿股内资股已入账列作缴足发行予认购方，本次发行已完成。因此，紧随本次发行完成后，本公司的已发行股份总数为6.26亿股，其中包括2.98亿股内资股、1200万股未上市外资股及3.16亿股H股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382803.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2588773780","title":"瑞科生物-B(02179)提名魏其芳及王静担任公司执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2588773780","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588773780?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:09","pubTimestamp":1764598180,"startTime":"0","endTime":"0","summary":"智通财经APP讯，瑞科生物-B 发布公告，公司董事会于2025年12月1日收到李布先生、陈青青女士及洪坤学博士的辞职报告。陈青青女士因其个人原因及计划倾注更多时间于其他工作，辞去公司执行董事、董事会提名委员会委员及联席公司秘书职务。彼等的辞职报告自送达董事会之日起生效。董事会于2025年12月1日召开的董事会会议上提名徐浩宇先生担任公司非执行董事，提名魏其芳先生及王静女士担任公司执行董事。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376229.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"1174682681","title":"江蘇瑞科生物（2179）更新2025年11月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1174682681","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174682681?lang=zh_cn&edition=full","pubTime":"2025-12-01 12:10","pubTimestamp":1764562236,"startTime":"0","endTime":"0","summary":"江蘇瑞科生物技術股份有限公司（股票代码：02179）于2025年12月1日发布2025年11月股份变动月报表。报告期内，公司已发行内资股为154,824,311股，非上市外资股为12,000,000股，H股为316,138,689股，三类股份数量均无增减变动，法定/注册股本总额维持人民币482,963,000元。\n根据月报显示，公司当月未有新增发行、购回、注销或库藏股活动，也未涉及任何股份期权、可换股票据或其他股权激励计划变动。截至2025年11月30日，公司股权结构及已发行股份总数保持稳定。\n公告显示，公司确认遵守香港联交所《上市规则》及相关法律规定。本次月报由公司董事刘勇签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02179"],"gpt_icon":0},{"id":"2584063836","title":"瑞科生物-B大跌5.27% 近日取得重组带状疱疹疫苗《药品生产许可证》增项","url":"https://stock-news.laohu8.com/highlight/detail?id=2584063836","media":"港美通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584063836?lang=zh_cn&edition=full","pubTime":"2025-11-17 14:36","pubTimestamp":1763361413,"startTime":"0","endTime":"0","summary":"11月17日14:21，瑞科生物-B股价大幅下跌5.27%。消息面上，瑞科生物近日发布公告称，公司已获得江苏省药品监督管理局颁发的《药品生产许可证》增项批准，新增重组带状疱疹疫苗及相关佐剂成分的生产范围。本次增项标志着本集团在预防用生物制品领域的研发与生产能力实现进一步拓展，为后续药品上市注册奠定坚实基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117144027a6fea606&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117144027a6fea606&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2583505876","title":"瞄准老龄化市场：瑞科生物重组带状疱疹疫苗生产许可增项获批，商业化提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2583505876","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583505876?lang=zh_cn&edition=full","pubTime":"2025-11-14 20:22","pubTimestamp":1763122965,"startTime":"0","endTime":"0","summary":"11月14日，瑞科生物（02179）发布公告，近日公司获得江苏省药品监督管理局颁发的《药品生产许可证》增项批准，新增重组带状疱疹疫苗（CHO细胞）及相关佐剂成分的生产范围。本次增项生效日期为2025年11月5日，有效期至2026年11月14日，标志着公司在预防用生物制品领域的研发与生产能力实现进一步拓展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511143565008996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2576510724","title":"瑞科生物-B：完成定向发行内资股的缴款及验资","url":"https://stock-news.laohu8.com/highlight/detail?id=2576510724","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576510724?lang=zh_cn&edition=full","pubTime":"2025-10-16 16:54","pubTimestamp":1760604840,"startTime":"0","endTime":"0","summary":"格隆汇10月16日丨瑞科生物-B公布，有关公司建议定向发行内资股及其相关事宜，以及关于定向发行内资股获中国证券监督管理委员会的批复。截至本公告日期，本次发行的募集资金已缴足，并已由根据中国法律设立的验资机构审验并出具验资报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016165916a6bcb9f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016165916a6bcb9f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2575044235","title":"瑞科生物-B10月13日主力净流出179.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2575044235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575044235?lang=zh_cn&edition=full","pubTime":"2025-10-13 16:15","pubTimestamp":1760343345,"startTime":"0","endTime":"0","summary":"10月13日, 瑞科生物-B股价跌0.88%，报收6.79元，成交金额196.2万元，换手率0.09%，振幅4.23%，量比9.21。瑞科生物-B今日主力资金净流出179.9万元，上一交易日主力净流出0万元。该股近5个交易日下跌3.95%，主力资金累计净流出163.6万元；近20日主力资金累计净流出238.2万元，其中净流出天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013162000a45d487c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013162000a45d487c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2571343231","title":"瑞科生物-B09月30日主力净流出22.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2571343231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571343231?lang=zh_cn&edition=full","pubTime":"2025-09-30 16:15","pubTimestamp":1759220151,"startTime":"0","endTime":"0","summary":"09月30日, 瑞科生物-B股价跌5.54%，报收7.16元，成交金额37.5万元，换手率0.02%，振幅5.01%，量比4.30。瑞科生物-B今日主力资金净流出22.7万元，上一交易日主力净流出0万元。该股近5个交易日下跌4.53%，主力资金累计净流出22.7万元；近20日主力资金累计净流出74.5万元，其中净流出天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930162105a6a7fcf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930162105a6a7fcf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2567188441","title":"瑞科生物-B09月12日主力净流出51.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2567188441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567188441?lang=zh_cn&edition=full","pubTime":"2025-09-12 16:15","pubTimestamp":1757664951,"startTime":"0","endTime":"0","summary":"09月12日, 瑞科生物-B股价跌1.67%，报收7.67元，成交金额85.2万元，换手率0.04%，振幅5.00%，量比4.01。瑞科生物-B今日主力资金净流出51.8万元，上一交易日主力净流出0万元。该股近5个交易日上涨2.27%，主力资金累计净流出51.8万元；近20日主力资金累计净流出15.5万元，其中净流出天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091216215195281d3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091216215195281d3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2563307506","title":"瑞科生物-B公布中期业绩 研发成本大幅增加46.0% 推进国际化战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2563307506","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563307506?lang=zh_cn&edition=full","pubTime":"2025-08-29 19:24","pubTimestamp":1756466672,"startTime":"0","endTime":"0","summary":"格隆汇8月29日丨瑞科生物-B发布公告，截至2025年6月30日止六个月，公司收入由截至2024年6月30日止六个月的无增加至人民币10.9百万元，该等增加主要是由于公司于本期授予知识产权许可产生收入。公司的研发成本由上年同期的人民币205.2百万元增加46.0%至截至2025年6月30日止六个月的人民币299.6百万元。截至本公告日期，公司的疫苗组合包括10余款候选疫苗。公司将采取病理学终点进行期中分析，满足条件后预期将在2026年提交BLA申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082919274795056be0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082919274795056be0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":-0.1364},{"period":"3month","weight":-0.1862},{"period":"6month","weight":-0.3618},{"period":"1year","weight":-0.4565},{"period":"ytd","weight":0.235}],"compareEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":0.0069},{"period":"3month","weight":-0.0015},{"period":"6month","weight":0.0697},{"period":"1year","weight":0.2367},{"period":"ytd","weight":0.0547}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。该公司尚处于研发阶段。该公司的疫苗管线包括重组九价人乳头瘤病毒（HPV）、新佐剂重组九价HPV疫苗、重组二价（16/18）HPV疫苗、重组二价（6/11）HPV疫苗、新佐剂重组四价HPV疫苗、新佐剂重组带状疱疹病疫苗、新佐剂重组呼吸道合胞病毒疫苗、重组偏肺病毒疫苗、重组人巨细胞病毒疫苗、重组双组分新冠病毒疫苗、重组乙型肝炎病毒疫苗等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.009257},{"month":2,"riseRate":0.25,"avgChangeRate":-0.036791},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.06484},{"month":4,"riseRate":0.25,"avgChangeRate":-0.083572},{"month":5,"riseRate":0.25,"avgChangeRate":-0.027385},{"month":6,"riseRate":0.25,"avgChangeRate":-0.013774},{"month":7,"riseRate":0.5,"avgChangeRate":-0.016314},{"month":8,"riseRate":0.25,"avgChangeRate":-0.033938},{"month":9,"riseRate":0.25,"avgChangeRate":-0.012227},{"month":10,"riseRate":0.5,"avgChangeRate":0.027812},{"month":11,"riseRate":0,"avgChangeRate":-0.140794},{"month":12,"riseRate":0.75,"avgChangeRate":0.059254}],"exchange":"SEHK","name":"瑞科生物-B","nameEN":"RECBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞科生物-B(02179)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞科生物-B(02179)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞科生物-B,02179,瑞科生物-B股票,瑞科生物-B股票老虎,瑞科生物-B股票老虎国际,瑞科生物-B行情,瑞科生物-B股票行情,瑞科生物-B股价,瑞科生物-B股市,瑞科生物-B股票价格,瑞科生物-B股票交易,瑞科生物-B股票购买,瑞科生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞科生物-B(02179)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞科生物-B(02179)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}